Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | FAM66D |
| Upstream (Parents) |
|---|
| (<<) EML1 → FAM66D |
| (<<) RTN1 → FAM66D |
| (<<) CACNA1F → FAM66D |
| (<<) HLTF → FAM66D |
| (<<) ALDH1A3 → FAM66D |
| (<<) CD1C → FAM66D |
| (<<) THAP9 → FAM66D |
| (<<) LIMCH1 → FAM66D |
| Downstream (Children) |
|---|
| FAM66D → CACNA1F (>>) |
| FAM66D → ZBTB1 (>>) |
| FAM66D → F2RL2 (>>) |
| FAM66D → TACR3 (>>) |
